Sunshine Biopharma Inc. Quarterly Return On Equity in % from Q2 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Sunshine Biopharma Inc. quarterly/annual Return On Equity history and growth rate from Q2 2012 to Q3 2024.
  • Sunshine Biopharma Inc. Return On Equity for the quarter ending September 30, 2024 was -17.9 %, a 85.6% increase year-over-year.
  • Sunshine Biopharma Inc. annual Return On Equity for 2023 was -21 %, a 77% increase from 2022.
  • Sunshine Biopharma Inc. annual Return On Equity for 2022 was -91.3 %, a 105% decline from 2021.
  • Sunshine Biopharma Inc. annual Return On Equity for 2021 was 1.7K %, a 328% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -17.9 +106 +85.6% Jul 1, 2024 Sep 30, 2024
Q2 2024 -16.1 +89.4 +84.8% Apr 1, 2024 Jun 30, 2024
Q1 2024 -18 +70.3 +79.7% Jan 1, 2024 Mar 31, 2024
Q4 2023 -21 +70.2 +77% Oct 1, 2023 Dec 31, 2023
Q3 2023 -124 -114 -1061% Jul 1, 2023 Sep 30, 2023
Q2 2023 -105 -67.5 -178% Apr 1, 2023 Jun 30, 2023
Q1 2023 -88.3 +173 +66.2% Jan 1, 2023 Mar 31, 2023
Q4 2022 -91.3 -1.8K -105% Oct 1, 2022 Dec 31, 2022
Q3 2022 -10.7 -1.4K -101% Jul 1, 2022 Sep 30, 2022
Q2 2022 -38 -1.29K -103% Apr 1, 2022 Jun 30, 2022
Q1 2022 -261 -1.38K -123% Jan 1, 2022 Mar 31, 2022
Q4 2021 1.7K +1.31K +328% Oct 1, 2021 Dec 31, 2021
Q3 2021 1.39K +1.06K +327% Jul 1, 2021 Sep 30, 2021
Q2 2021 1.25K +998 +395% Apr 1, 2021 Jun 30, 2021
Q1 2021 1.12K +913 +442% Jan 1, 2021 Mar 31, 2021
Q4 2020 398 +133 +50.3% Oct 1, 2020 Dec 31, 2020
Q3 2020 326 -25.3 -7.21% Jul 1, 2020 Sep 30, 2020
Q2 2020 253 -578 -69.6% Apr 1, 2020 Jun 30, 2020
Q1 2020 207 -1.47K -87.7% Jan 1, 2020 Mar 31, 2020
Q4 2019 265 -830 -75.8% Oct 1, 2019 Dec 31, 2019
Q3 2019 351 -271 -43.6% Jul 1, 2019 Sep 30, 2019
Q2 2019 831 +533 +179% Apr 1, 2019 Jun 30, 2019
Q1 2019 1.68K +1.46K +672% Jan 1, 2019 Mar 31, 2019
Q4 2018 1.09K +864 +375% Oct 1, 2018 Dec 31, 2018
Q3 2018 622 +79.4 +14.7% Jul 1, 2018 Sep 30, 2018
Q2 2018 298 -1.48K -83.2% Apr 1, 2018 Jun 30, 2018
Q1 2018 217 -1.97K -90.1% Jan 1, 2018 Mar 31, 2018
Q4 2017 231 -1.73K -88.2% Oct 1, 2017 Dec 31, 2017
Q3 2017 542 -551 -50.4% Jul 1, 2017 Sep 30, 2017
Q2 2017 1.77K +1.4K +379% Apr 1, 2017 Jun 30, 2017
Q1 2017 2.19K +1.76K +410% Jan 1, 2017 Mar 31, 2017
Q4 2016 1.96K +1.5K +323% Oct 1, 2016 Dec 31, 2016
Q3 2016 1.09K +633 +137% Jul 1, 2016 Sep 30, 2016
Q2 2016 371 -140 -27.4% Apr 1, 2016 Jun 30, 2016
Q1 2016 429 -131 -23.4% Jan 1, 2016 Mar 31, 2016
Q4 2015 464 -230 -33.1% Oct 1, 2015 Dec 31, 2015
Q3 2015 461 -752 -62% Jul 1, 2015 Sep 30, 2015
Q2 2015 510 -1.56K -75.4% Apr 1, 2015 Jun 30, 2015
Q1 2015 561 +8.83K Jan 1, 2015 Mar 31, 2015
Q4 2014 694 +3.05K Oct 1, 2014 Dec 31, 2014
Q3 2014 1.21K +2.81K Jul 1, 2014 Sep 30, 2014
Q2 2014 2.07K +3.31K Apr 1, 2014 Jun 30, 2014
Q1 2014 -8.27K -6.93K -517% Jan 1, 2014 Mar 31, 2014
Q4 2013 -2.36K -1.75K -288% Oct 1, 2013 Dec 31, 2013
Q3 2013 -1.59K -878 -123% Jul 1, 2013 Sep 30, 2013
Q2 2013 -1.24K -700 -129% Apr 1, 2013 Jun 30, 2013
Q1 2013 -1.34K Jan 1, 2013 Mar 31, 2013
Q4 2012 -607 Oct 1, 2012 Dec 31, 2012
Q3 2012 -715 Jul 1, 2012 Sep 30, 2012
Q2 2012 -543 Apr 1, 2012 Jun 30, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.